Avascular Osteonecrosis of the Jaw as a Side Effect of Bisphosphonate Treatment

被引：7
作者：
Bamias, Aristotle [1 ]
Terpos, Evangelos [1 ]
Dimopoulos, Meletios A. [1 ]
机构：
[1] Univ Athens, Sch Med, Dept Clin Therapeut, GR-10679 Athens, Greece
来源：
ONKOLOGIE | 2010年 / 33卷 / 06期
关键词：
CANCER;
D O I：
10.1159/000313684
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：288 / 289
页数：2
相关论文
共 11 条
  • [1] Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors
    Bamias, A
    Kastritis, E
    Bamia, C
    Moulopoulos, LA
    Melakopoulos, L
    Bozas, G
    Koutsoukou, V
    Gika, D
    Anagnostopoulos, A
    Papadimitriou, C
    Terpos, E
    Dimopoulos, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8580 - 8587
  • [2] Osteonecrosis of the Jaw after a Single Bisphosphonate Infusion in a Patient with Metastatic Renal Cancer Treated with Sunitinib
    Bozas, George
    Roy, Anu
    Ramasamy, Vani
    Maraveyas, Anthony
    [J]. ONKOLOGIE, 2010, 33 (06): : 321 - 323
  • [3] Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone
    Christodoulou, C.
    Pervena, A.
    Klouvas, G.
    Galani, E.
    Falagas, M. E.
    Tsakalos, G.
    Visvikis, A.
    Nikolakopoulou, A.
    Acholos, V.
    Karapanagiotidis, G.
    Batziou, E.
    Skarlos, D. V.
    [J]. ONCOLOGY, 2009, 76 (03) : 209 - 211
  • [4] CLARKE BKS, BISPHOSPHONATE ASS O
  • [5] Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
    Dimopoulos, M. A.
    Kastritis, E.
    Bamia, C.
    Melakopoulos, I.
    Gika, D.
    Roussou, M.
    Migkou, M.
    Eleftherakis-Papaiakovou, E.
    Christoulas, D.
    Terpos, E.
    Bamias, A.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (01) : 117 - 120
  • [6] Osteonecrosis of the jaw related to bevacizumab
    Estilo, Cherry L.
    Fornier, Monica
    Farooki, Azeez
    Carlson, Diane
    Bohle, George, III
    Huryn, Joseph M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 4037 - 4038
  • [7] Bevacizumab-associated osteonecrosis of the jaw
    Greuter, S.
    Schmid, F.
    Ruhstaller, T.
    Thuerlimann, B.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (12) : 2091 - U3
  • [8] Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents
    Kastritis, Efstathios
    Anagnostopoulos, Athanasios
    Roussou, Maria
    Gika, Dimitra
    Matsouka, Charis
    Barmparousi, Despina
    Grapsa, Irini
    Psimenou, Erasmia
    Bamias, Aristotle
    Dimopoulos, Meletios Athanasios
    [J]. HAEMATOLOGICA, 2007, 92 (04) : 546 - 549
  • [9] Managing the care of patients with bisphosponate-associated osteonecrosis - An American Academy of Oral Medicine position paper
    Migliorati, CA
    Casiglia, J
    Epstein, J
    Jacobsen, PL
    Siegel, MA
    Woo, SB
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2005, 136 (12) : 1658 - 1668
  • [10] Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients
    Vincenzi, B
    Santini, D
    Dicuonzo, G
    Battistoni, F
    Gavasci, M
    La Cesa, A
    Grilli, C
    Virzì, V
    Gasparro, S
    Rocci, L
    Tonini, G
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (03) : 144 - 151
12